Zensun (Shanghai) Sci & Tech
Recombinant neuregulin biologics for heart failure
Privately held: no public share price · China
Assets
(1 total)
1Total Assets
0Approved
1Phase 3 / Filed
0Phase 1–2 / Early
1Diseases
| Target & Modality | |||
|---|---|---|---|
Recombinant human neuregulin-1 (rhNRG-1)(Neucardin) | Phase 3 | ErbB2/ErbB4 (neuregulin pathway)Protein / enzyme therapeutic | Heart Failure |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.